NIH-Supported Trial Addresses Barrier to OUD Treatment
The US Food & Drug Administration (FDA) recently approved the Edwards EVOQUE Tricuspid Valve Replacement System – P230013.
Posted in:
opioids 10
The US Food & Drug Administration (FDA) recently approved the Edwards EVOQUE Tricuspid Valve Replacement System – P230013.
Membership grants access to journals, courses and a slew of premium benefits.
Please consider supporting us by choosing an option below:
View Membership Options Make A Tax-Deductable Donation
No Thanks, take me to the site and don't show me this again.